Affimed Pocfratio vs Ev To Free Cash Flow Analysis
AFMD Stock | USD 2.64 0.08 2.94% |
Affimed NV financial indicator trend analysis is way more than just evaluating Affimed NV prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Affimed NV is a good investment. Please check the relationship between Affimed NV Pocfratio and its Ev To Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.
Pocfratio vs Ev To Free Cash Flow
Pocfratio vs Ev To Free Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Affimed NV Pocfratio account and Ev To Free Cash Flow. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Affimed NV's Pocfratio and Ev To Free Cash Flow is 0.83. Overlapping area represents the amount of variation of Pocfratio that can explain the historical movement of Ev To Free Cash Flow in the same time period over historical financial statements of Affimed NV, assuming nothing else is changed. The correlation between historical values of Affimed NV's Pocfratio and Ev To Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pocfratio of Affimed NV are associated (or correlated) with its Ev To Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Free Cash Flow has no effect on the direction of Pocfratio i.e., Affimed NV's Pocfratio and Ev To Free Cash Flow go up and down completely randomly.
Correlation Coefficient | 0.83 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Pocfratio
Ev To Free Cash Flow
A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.Most indicators from Affimed NV's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Affimed NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.At present, Affimed NV's Enterprise Value is projected to decrease significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 712K | 1.6M | 1.8M | 1.8M | Depreciation And Amortization | 1.4M | 2.8M | 1.7M | 1.8M |
Affimed NV fundamental ratios Correlations
Click cells to compare fundamentals
Affimed NV Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Affimed NV fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 112.4M | 175.7M | 225.1M | 200.5M | 97.2M | 105.8M | |
Short Long Term Debt Total | 3.2M | 1.3M | 18.7M | 18.2M | 19.4M | 11.4M | |
Other Current Liab | 24.3M | 517K | 58.5M | 46.2M | 53.1M | 55.8M | |
Total Current Liabilities | 35.2M | 67.0M | 64.5M | 34.7M | 25.9M | 28.4M | |
Total Stockholder Equity | 38.7M | 72.0M | 136.0M | 152.9M | 57.8M | 45.3M | |
Other Liab | 37.5M | 38.0M | 36.0M | 7.2M | 8.3M | 15.7M | |
Property Plant And Equipment Net | 3.1M | 3.2M | 4.8M | 4.4M | 12.9M | 13.6M | |
Current Deferred Revenue | 21.4M | 55.0M | 44.4M | 9.2M | 619K | 588.1K | |
Net Debt | (92.0M) | (145.6M) | (178.9M) | (172.1M) | (19.2M) | (20.1M) | |
Retained Earnings | (234.5M) | (275.9M) | (333.4M) | (430.2M) | (536.1M) | (509.3M) | |
Accounts Payable | 10.7M | 11.4M | 18.9M | 19.1M | 18.9M | 10.3M | |
Cash | 95.2M | 146.9M | 197.6M | 190.3M | 38.5M | 36.6M | |
Non Current Assets Total | 6.4M | 24.9M | 18.7M | 4.4M | 13.0M | 7.3M | |
Long Term Debt | 278K | 231K | 17.1M | 11.7M | 6.3M | 6.0M | |
Cash And Short Term Investments | 104.1M | 146.9M | 197.6M | 190.3M | 72.9M | 94.5M | |
Net Receivables | 1.5M | 2.4M | 4.8M | 2.7M | 5.3M | 5.6M | |
Common Stock Total Equity | 468K | 624K | 762K | 983K | 1.1M | 1.2M | |
Common Stock Shares Outstanding | 6.4M | 8.3M | 12.0M | 14.2M | 14.9M | 15.7M | |
Liabilities And Stockholders Equity | 112.4M | 175.7M | 225.1M | 200.5M | 97.2M | 105.8M | |
Non Current Liabilities Total | 38.5M | 36.7M | 24.6M | 12.9M | 13.4M | 23.3M | |
Inventory | 296K | 246K | 421K | 628K | 463K | 315.3K | |
Other Stockholder Equity | 273.2M | 346.9M | 468.1M | 469.3M | 539.8M | 566.7M | |
Total Liab | 73.7M | 103.7M | 89.2M | 47.6M | 39.4M | 60.4M | |
Property Plant And Equipment Gross | 3.1M | 3.2M | 4.8M | 4.4M | 16.0M | 16.8M | |
Total Current Assets | 105.9M | 150.8M | 206.4M | 196.1M | 84.2M | 98.5M | |
Accumulated Other Comprehensive Income | 272.4M | 346.9M | 468.1M | 581.6M | 592.4M | 622.1M | |
Intangible Assets | 137K | 1.7M | 1.6M | 58K | 25K | 23.8K | |
Common Stock | 762K | 983K | 1.2M | 1.5M | 1.5M | 1.6M | |
Property Plant Equipment | 1.4M | 3.1M | 3.2M | 4.8M | 5.5M | 5.8M | |
Net Tangible Assets | 40.1M | 38.5M | 70.3M | 134.3M | 154.5M | 162.2M | |
Short Long Term Debt | 2.1M | 92K | 580K | 5.9M | 5.8M | 8.3M | |
Short Term Debt | 2.6M | 584K | 1.3M | 6.3M | 6.4M | 3.4M | |
Capital Lease Obligations | 804K | 974K | 1.1M | 572K | 7.2M | 7.6M | |
Other Current Assets | 8.9M | 1.3M | 3.5M | (2.7M) | 5.5M | 5.8M | |
Net Invested Capital | 41.1M | 72.3M | 153.6M | 170.5M | 70.0M | 92.9M | |
Net Working Capital | 70.7M | 83.8M | 141.8M | 161.4M | 58.3M | 98.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Affimed NV is a strong investment it is important to analyze Affimed NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Affimed NV's future performance. For an informed investment choice regarding Affimed Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.80) | Revenue Per Share 0.493 | Quarterly Revenue Growth (0.90) | Return On Assets (0.49) | Return On Equity (1.24) |
The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.